Asia Pacific RNA-Based Therapeutics Market Analysis and In-depth Research on Market Size, Trends, Emerging Growth Factors and Regional Forecasts to 2023
The Asia-Pacific RNA-based therapeutics market is growing at a promising CAGR due to the gene silencing potential of these therapeutics. However, the market is still at the nascent stage in developing regions such as India and witnessing the lucrative growth rate during the analysis period. Factors that would fuel the market growth in Asia-Pacific region are target specificity and selectivity of RNAi therapeutics, more intense product focus versus platform technologies and virtual drug development models that enable companies to reduce the research cost. However, high cost coupled with the high failure rates and reimbursement issues related with the adoption of RNA-based therapeutics would restrain the market growth.
Buy now and get FREE One Month Knowledge Tree Subscription (valid till 30 Nov'18):
• This report includes extensive coverage of the Asia-Pacific RNA-based therapeutics market including drivers, restraints and opportunities that would help professionals to better understand market behavior
• Analyzing the current market trends, projections regarding the market potential for the period of 20142021 in terms of value are discussed
• A comprehensive analysis of device types, end users and geography segments enables the identification of growth opportunities within the Asia-Pacific RNA-based therapeutics market
• Market attractiveness analysis for the market would provide strategic assistance to decision makers
• An analysis of strategies used by key leaders within the Asia-Pacific RNA-based therapeutics market would prove to be informative for professionals in the corporate sector
• Porters five forces framework examines the competitive structure of Asia-Pacific RNA-based therapeutics market and would be helpful for strategic industry analysis
• Ease of doing business analysis would help in making strategic business decisions
The Asia-Pacific RNA-based therapeutics market is segmented on the basis of technology, application, end user and geography. Based on technology, the market is segmented into enabling technologies, enabled technologies and RNA antisense technologies. Owing to the applications, the market is segmented into cardiovascular diseases, kidney diseases, oncology infectious diseases and metabolic disorders.
Get sample copy of this report :
Top key Players :
• Genzyme Corporation
• Tekmira Pharmaceuticals Corp
• Biocon ltd
• Nitto Denko Corporation
• Alnylam Pharmaceuticals
• Inc. Acorda Therapeutics Inc.
• Arrowhead Research Corporation
• Abingworth Life Science
• Silence Therapeutics PLC
• AstraZeneca Inc.
• Catalyst Biosciences.
Based on the end users, the market is categorized into diagnostic, therapeutic and research organizations. Geographically, the market is segmented into China, Japan, India, Australia and others. Emerging economies such as India, China, Singapore and Malaysia are the potential geographies for market expansion due to improving healthcare standards. These economies have a large presence of domestic manufacturers of RNA-based therapeutics, which contribute to an increase in the market competition for multinational giants by adopting the strategy of price penetration.
Get Access to Full summary of this report at :
Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific RNA-Based Therapeutics Market Analysis and In-depth Research on Market Size, Trends, Emerging Growth Factors and Regional Forecasts to 2023 here
News-ID: 1405698 • Views: 263
More Releases from Allied Market Research
Europe Insecticides Market reach $23.36 billion by 2026, growing at a CAGR of 5. …
According to the report, the Europe insecticides market for waste management accounted for $14.73 billion in 2018 and is anticipated to reach $23.36 billion by 2026, growing at a CAGR of 5.8% from 2019 to 2026. Generation of waste in huge amount and upsurge in number of insects drive the growth in the market. However, storage and handling of insecticides restrain the market growth. On the other hand, stringent regulations for
Trauma Devices Market Is Projected To Grow Exponentially By 2022 | major key pla …
Trauma devices are one of the various clinical procedures used for the treatment of trauma based upon the severity of injury. Trauma refers to any kind of physical injury such as fractures, dislocations, sprains & strains and burns caused by any external source. According to Center for Disease Control and Prevention, Trauma is an injury or wound to a living individual caused by due to violence or external force. These
3D Medical Imaging Market Size anticipated to witness significant growth by 2026 …
3D imaging is a revolutionary optical imaging technology that provides an enriched images on 2D platforms. This technology has the ability to offer enhanced imaging solutions in various sectors, from healthcare to entertainment to architecture modelling. Improved imaging and better viewing experience are the main attributes for its increasing demand. Moreover, the emergence of this imaging technique has allowed medical professionals to generate an in-depth image of suspect for better
Near Infrared Imaging Market Trends and Industry Analysis,Growth Prospect, durin …
Near infrared imaging is a non-invasive imaging technique that uses non-ionizing rays which helps in the detection of amount of hemoglobin present in brain and body tissues and muscles. The development of near infrared imaging has allowed the clinicians to detect brain injuries and other brain related disorders. Along with this, near infrared imaging is also being applied to diagnose breast cancer, alzheimer’s disease, depression and schizophrenia. Moreover this technique
More Releases for RNA
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led